Roxana Mehran

In this insightful discussion, Roxana Mehran, a leading cardiologist and vice president of the American College of Cardiology, shares her expertise on the importance of clinical trial representativeness. She discusses the challenges of recruiting diverse populations and suggests actionable strategies for enhancing inclusivity in trials. Mehran emphasizes how community engagement and demographic considerations can improve outcomes and trust in clinical research. The conversation highlights the growing role of industry in ensuring that clinical trials reflect the populations they aim to serve.